These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12523668)

  • 1. Enthalpy relaxation studies of celecoxib amorphous mixtures.
    Kakumanu VK; Bansal AK
    Pharm Res; 2002 Dec; 19(12):1873-8. PubMed ID: 12523668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective.
    Gupta P; Kakumanu VK; Bansal AK
    Pharm Res; 2004 Oct; 21(10):1762-9. PubMed ID: 15553220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Factors Governing the Liquid and Glassy States Recrystallization of Celecoxib in Binary Mixtures with Excipients of Different Molecular Weights.
    Grzybowska K; Chmiel K; Knapik-Kowalczuk J; Grzybowski A; Jurkiewicz K; Paluch M
    Mol Pharm; 2017 Apr; 14(4):1154-1168. PubMed ID: 28241116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of molecular interaction in stability of celecoxib-PVP amorphous systems.
    Gupta P; Thilagavathi R; Chakraborti AK; Bansal AK
    Mol Pharm; 2005; 2(5):384-91. PubMed ID: 16196491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Dynamics and Physical Stability of Pharmaceutical Co-amorphous Systems: Correlation Between Structural Relaxation Times Measured by Kohlrausch-Williams-Watts With the Width of the Glass Transition Temperature (ΔT
    Chieng N; Teo X; Cheah MH; Choo ML; Chung J; Hew TK; Keng PS
    J Pharm Sci; 2019 Dec; 108(12):3848-3858. PubMed ID: 31542436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Devitrification of amorphous celecoxib.
    Gupta P; Bansal AK
    AAPS PharmSciTech; 2005 Sep; 6(2):E223-30. PubMed ID: 16353981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amorphous Salts Solid Dispersions of Celecoxib: Enhanced Biopharmaceutical Performance and Physical Stability.
    Mukesh S; Joshi P; Bansal AK; Kashyap MC; Mandal SK; Sathe V; Sangamwar AT
    Mol Pharm; 2021 Jun; 18(6):2334-2348. PubMed ID: 34003656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enthalpy relaxation studies of two structurally related amorphous drugs and their binary dispersions.
    Bansal SS; Kaushal AM; Bansal AK
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1271-80. PubMed ID: 20815794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different or the same? exploring the physicochemical properties and molecular mobility of celecoxib amorphous forms.
    Wang M; Aalling-Frederiksen O; Madsen AØ; Jensen KMØ; Jørgensen MRV; Gong J; Rades T; Martins ICB
    Int J Pharm; 2024 Aug; 661():124470. PubMed ID: 39004294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of surfactants on the crystal growth of amorphous celecoxib.
    Mosquera-Giraldo LI; Trasi NS; Taylor LS
    Int J Pharm; 2014 Jan; 461(1-2):251-7. PubMed ID: 24333451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility.
    Gupta P; Chawla G; Bansal AK
    Mol Pharm; 2004; 1(6):406-13. PubMed ID: 16028352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential.
    Remenar JF; Peterson ML; Stephens PW; Zhang Z; Zimenkov Y; Hickey MB
    Mol Pharm; 2007; 4(3):386-400. PubMed ID: 17497886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions.
    Andrews GP; Abu-Diak O; Kusmanto F; Hornsby P; Hui Z; Jones DS
    J Pharm Pharmacol; 2010 Nov; 62(11):1580-90. PubMed ID: 21072971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spray drying for generation of a ternary amorphous system of celecoxib, PVP, and meglumine.
    Gupta P; Bansal AK
    Pharm Dev Technol; 2005; 10(2):273-81. PubMed ID: 15926676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glass transition and enthalpy relaxation of amorphous lactose glass.
    Haque MK; Kawai K; Suzuki T
    Carbohydr Res; 2006 Aug; 341(11):1884-9. PubMed ID: 16709405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interactions in celecoxib-PVP-meglumine amorphous system.
    Gupta P; Bansal AK
    J Pharm Pharmacol; 2005 Mar; 57(3):303-10. PubMed ID: 15807985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form.
    Ambrogi V; Perioli L; Marmottini F; Rossi C
    Eur J Pharm Biopharm; 2007 May; 66(2):253-9. PubMed ID: 17123798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of amorphous celecoxib stability by mixing it with octaacetylmaltose: the molecular dynamics study.
    Grzybowska K; Paluch M; Wlodarczyk P; Grzybowski A; Kaminski K; Hawelek L; Zakowiecki D; Kasprzycka A; Jankowska-Sumara I
    Mol Pharm; 2012 Apr; 9(4):894-904. PubMed ID: 22384922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
    Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
    J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.